BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9570926)

  • 1. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities.
    Schmitt E; Cimoli G; Steyaert A; Bertrand R
    Exp Cell Res; 1998 Apr; 240(1):107-21. PubMed ID: 9570926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities.
    Sané AT; Bertrand R
    Cancer Res; 1998 Jul; 58(14):3066-72. PubMed ID: 9679972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
    Schmitt E; Sané AT; Steyaert A; Cimoli G; Bertrand R
    Biochem Cell Biol; 1997; 75(4):301-14. PubMed ID: 9493953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CrmA- and TPCK-sensitive pathways that trigger oligonucleosome-sized DNA fragmentation in camptothecin-induced apoptosis: relation to caspase activation and high molecular weight DNA fragmentation.
    Sané AT; Schmitt E; Steyaert A; Meyer D; Bertrand R
    Biochem Cell Biol; 1997; 75(4):359-68. PubMed ID: 9493958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B; Dubrez L; Allouche M; Solary E
    Cancer Res; 1997 Feb; 57(4):686-95. PubMed ID: 9044846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.
    Huang Y; Sheikh MS; Fornace AJ; Holbrook NJ
    Oncogene; 1999 Jun; 18(23):3431-9. PubMed ID: 10376521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death.
    Sané AT; Bertrand R
    Cancer Res; 1999 Aug; 59(15):3565-9. PubMed ID: 10446962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.
    Walton MI; Whysong D; O'Connor PM; Hockenbery D; Korsmeyer SJ; Kohn KW
    Cancer Res; 1993 Apr; 53(8):1853-61. PubMed ID: 8467505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
    Schmitt E; Steyaert A; Cimoli G; Bertrand R
    Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation.
    Schmitt E; Paquet C; Beauchemin M; Bertrand R
    Oncogene; 2004 May; 23(22):3915-31. PubMed ID: 15048082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies.
    Shimizu T; Pommier Y
    Exp Cell Res; 1996 Aug; 226(2):292-301. PubMed ID: 8806433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
    Fujita N; Nagahashi A; Nagashima K; Rokudai S; Tsuruo T
    Oncogene; 1998 Sep; 17(10):1295-304. PubMed ID: 9771973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
    Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP
    Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
    Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Okadaic acid induces DNA fragmentation via caspase-3-dependent and caspase-3-independent pathways in Chinese hamster ovary (CHO)-K1 cells.
    Kitazumi I; Maseki Y; Nomura Y; Shimanuki A; Sugita Y; Tsukahara M
    FEBS J; 2010 Jan; 277(2):404-12. PubMed ID: 19968860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis.
    Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A
    Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H; Bouchon A; Stahl H; Krammer PH
    Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.